Friday, September 24, 2010

Multiple Sclerosis Sufferers Got New FDA Approved Relapse Pill

Originally purposed as anti-rejection drug, fingolimod was approved by Food and Drug Administration as multiple sclerosis relapse pill. Named as Gilenya, this drug comes to be the first medication for slowing disability progression on multiple sclerosis sufferers, which can be taken as a daily pill.

At first, Novartis, the manufacturer of the drug, sought for MS cure FDA approval, just as what doctors and patients want. However, efforts to prove decreased brain lesions fell short. In the clinical trials, though, it became notable that relapse rates of those taking fingolimod decreased to almost half as compared to MS patients under widely used injectable beta-interferon therapy. Seeing the benefits of notable slow in relapses, the drug ended up as what it worked best.

Fingolimod or Gilenya works b reducing the circulation and the penetration into the brains of immune cells, which cause inflammatory damage to the brain cells as well as to the fatty sheaths protecting the connections between them. This means reduced risk of progressively disabling mobility and cognition problems caused by brain lesions due to episodes of inflammation.

Before taking the medication, multiple sclerosis patients need to know three of Gilenya’s serious side effects. If any of the following symptoms are experienced, call your trusted man in lab coats.

Gilenya can cause slow heart rate.
Symptoms include dizziness, tiredness, and slow or irregular heart beat. These can be experienced within the six hours after taking the first dose. In around one month, heart rate should go back to normal.

Gilenya can increase risk of infections.
Symptoms include fever, tiredness, body aches, chills, nausea and vomiting. The drug increases risk of infections because it lowers the number of lymphocytes or white blood cells in the blood, but will go back to normal within 2 months after stopping treatment.

Gilenya can cause blurred vision called macular edema.
Symptoms include blurriness or shadows in the center of the vision, blind spot in the center of the vision, sensitivity to lights, and unusually colored or tinted vision. These symptoms are similar to MS attack’s optic neuritis, and can surface after 3 to 4 months of starting with the medication. Diabetic people have higher risk.


Sunday, July 18, 2010

Painless Vaccines Can Be Available in the Future

How will you be able to take your kid to a doctor for a shot? Say that the vaccine doesn’t really hurt, that it’s but psychological pain that others experience? Or take them by force? The debate may end if the patch based vaccine make further developments, and be proved effective on human subjects.

When vaccine like flu shot is needed, parents need not worry about kids wanting not to see doctors in lab coats or medical scrubs. A group or researchers were able to develop vaccine patch, which parents themselves can easily administer at home. There’s no need to literally drag your child to a hospital to get them vaccinated, and force them to face their fear of needle. The patch vaccine provides painless vaccination.

What is this patch vaccine? It’s basically a patch with 100 pieces of 0.65 mm long microscopic needles which penetrate the outer layer of the skin and dissolve upon contact. It does not need to penetrate deeply because there are immune cells present just below the surface of the skin, said co-author of the study Prof. Richard Compans of Emory University Medical School.

The group tested the new technological development on groups of mice. The microneedles, loaded with influenza vaccine, one group of mice was patched, while another group received the drug through traditional hypodermic needles. After which they were with flu virus. At the end of three months, the tests showed patched created a more effective immune response on mice.

This promising new technology will be further tested, and if it proves effective even on human, traditional hypodermic needles can become obsolete and totally eradicated. At times, wherein emergency vaccination is needed, patch vaccines can be a real big help in administering the drug. No need even for medical training in delivering vaccine at all.